The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
ImmuPharma PLC, up 59% at 9.00 pence, 12-month range 4.80p-10.90p. ‘Delighted’ with positive data from the Lupuzor/P140 pharmacokinetic study, required by the US Food & Drug Administration, as part of the new optimised international Phase 3 trial of Lupuzor in lupus patients. Study shows PK study has met the key endpoints requested by the FDA. ‘This positive PK data now clears the path for commencement of all clinical studies within the P140 platform. In addition to lupus, there is a planned Phase 2a/3 pivotal trial in chronic inflammatory demyelinating polyneuropathy,’ company notes.
----------
Shearwater Group PLC, up 25% at 136.42 pence, 12-month range 70.00p-230.00p. Subsidiary Brookcourt Solutions wins ‘significant’ new contract win to the potential value of up to about £21.0 million with unnamed ‘leading telecommunications and media company’. Initial, secured value of the contract, across an initial three year term, is £12.9 million, with the contract including an option to extend by a further two years for a total additional value of about £8.0 million.
----------
AIM - LOSERS
----------
Amur Minerals Corp, down 13% at 1.50 pence, 12-month range 1.00p-3.90p. Notes no individual or entity tied to company’s AO Kun-Manie mine have been sanctioned in any round of EU, UK and US sanctions against Russia. Mine is in far east of Russia. Also notes flow of funds supporting AO Kun-Manie continue and company has now ensured sufficient cash reserves for the subsidiary covering budgeted costs through the first half 2022. Previously, AO Kun-Manie funds have been delivered to cover a 30 to 45 day period. Does say, however, company’s lead legal consul representation in Moscow, Bryan Cave Leighton Paisner, is suspending operations within Russia. Company is reviewing options for lead Russian legal representation.
----------
Copyright 2022 Alliance News Limited. All Rights Reserved.
